Posted on 9/2/20
Amtrak Partners With RB
Since the onset of COVID-19, Amtrak has led the way in ushering a new standard of safe travel. Today, Amtrak is building on its commitment to . . .
Posted on 9/1/20
SNA International Ranked 150 on Inc. 500 - Chief Science Officer Highlighted in Inc. Magazine Article
SNA International, LLC for the second consecutive year made the annual Inc. 500 list, the most prestigious ranking of the nation's fastest-growing private companies. SNA moved . . .
Posted on 9/1/20
MellingMedical Signs Distribution Agreement with Leica Microsystems
ALEXANDRIA, Va.--(BUSINESS WIRE)--MellingMedical, a leading supplier of medical supplies, equipment, devices and pharmaceuticals to federal health facilities across the country under the Department of Veteran Affairs . . .
Posted on 9/1/20
Kit Check Extends Partnership with Premier
WASHINGTON, D.C.--(BUSINESS WIRE)--Kit Check, the leader in automated and intelligent medication management solutions, today announced that Premier Inc. has extended its sole source partnership with the . . .
Posted on 9/1/20
Vanda Pharmaceuticals Provides Update on Tradipitant Development Program
Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today provided an update on its development program for tradipitant. Enrollment in Vanda's Phase III clinical study (VP-VLY-686-3303) in gastroparesis . . .
Posted on 8/31/20
Novavax: COVID-19 Gave It Fuel, But It's Running Near Empty
SummaryNVAX had run over 4,000% YTD at its peak.COVID-19 vaccine hype is giving it some much-needed fuel after failing two late-stage clinical trials in 2016 and . . .
Posted on 8/31/20
HealthWell Foundation Launches New Fund
The HealthWell Foundation, an independent non-profit that provides a financial lifeline for inadequately insured Americans, has launched a new fund to provide copayment and premium assistance . . .
Posted on 8/31/20
Novavax and Canada Reach Agreement in Principle to Acquire Novavax’ COVID-19 Vaccine
GAITHERSBURG, Md., Aug. 31, 2020 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq: NVAX), a late stage biotechnology company developing next-generation vaccines for serious infectious diseases, today announced . . .
Posted on 8/31/20
I-Mab Reports Financial Results for the Six Months Ended June 30 and Provides Corporate Update
I-Mab (Nasdaq: IMAB), a clinical stage biopharmaceutical company committed to the discovery, development and commercialization of novel biologics, today announced financial results for the six months ended . . .
Posted on 8/31/20
In the Race for a Coronavirus Vaccine, Can There Be Multiple Winners?
Everyone is wondering which company will win the race to produce a coronavirus vaccine. With 31 candidates in clinical development and six of those in phase . . .
Posted on 8/31/20
Has The COVID-19 Vaccine Stock Bubble Burst?
COVID-19 vaccine stocks have easily been the hottest niche across the entire market since March. Developmental-stage companies like Inovio Pharmaceuticals (NASDAQ:INO), Moderna (NASDAQ:MRNA), Novavax (NASDAQ:NVAX), Vaxart . . .
Posted on 8/31/20
Why Novavax's Coronavirus Vaccine Might Be First to Market
In the race for a COVID-19 vaccine, Novavax (NASDAQ:NVAX) would seem to be in fourth place. (And that's if we exclude the Russian and Chinese vaccine . . .
Posted on 8/31/20
Want to Buy Novavax Stock on the Dip? Now's the Time
After reaching an all-time high of $189.40 per share in early August, shares of coronavirus vaccine developer Novavax (NASDAQ:NVAX) have fallen by nearly 40%, to $114.62, . . .
Posted on 8/31/20
Johns Hopkins Technology Ventures FY20 Annual Report
Read about some of the great progress that was made at Johns Hopkins Technology Ventures (JHTV) this past year in our latest Annual Report!
Posted on 8/28/20
Ambu Awarded National Single-Use Endoscopy Contract with Premier
Ambu Inc., the world leader in single-use endoscopes, announced today that it has been awarded a single-use endoscopy contract in the category of Surgical Disposable Scopes . . .
Posted on 8/28/20
Pharmaceutical Investments to Purchase During the COVID-19 Crisis
Pharmaceutical investments to purchase during the COVID-19 crisis include two traditional industry giants and an exchange-traded fund (ETF) that offers exposure to stocks that are pursuing . . .
Posted on 8/26/20
Delta Dental Community Care Foundation Awards $195,000 in Grants to West Virginia Nonprofits
The Delta Dental Community Care Foundation has given grants to 11 organizations, totaling $195,000, in West Virginia to provide relief amid the COVID-19 pandemic. These unrestricted . . .
Posted on 8/26/20
Delta Dental Community Care Foundation Awards $475,000 in Grants to Washington, D.C. Nonprofits
The Delta Dental Community Care Foundation has given grants to seven organizations, totaling $475,000, in Washington, D.C. to provide relief amid the COVID-19 pandemic. These unrestricted . . .
Posted on 8/26/20
Novavax Continues Progress: Latest COVID-19 Data Shows Encouraging Signs Of Advancement
SummaryNovavax achieved positive preliminary data in patients with COVID-19.Early data shows that all those who were given NVX-CoV2373 achieved anti-spike IgG antibodies and neutralization titers.Novavax expanded . . .
Posted on 8/26/20
Novavax Continues Progress: Latest COVID-19 Data Shows Encouraging Signs Of Advancement
SummaryNovavax achieved positive preliminary data in patients with COVID-19.Early data shows that all those who were given NVX-CoV2373 achieved anti-spike IgG antibodies and neutralization titers.Novavax expanded . . .
Posted on 8/25/20
Novavax Starts Phase 2 Coronavirus Vaccine Clinical Trial
Novavax (NASDAQ:NVAX) is behind the leaders in the race to develop a coronavirus vaccine to prevent COVID-19, but the biotech continues to trot along. On the . . .
Posted on 8/24/20
Catalent Signs Agreement with AstraZeneca
SOMERSET, N.J.--(BUSINESS WIRE)--Catalent, Inc. (NYSE: CTLT), the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and . . .
Posted on 8/24/20
RNAimmune Closed Seed Funding of $2.35M for Development of mRNA Therapeutics and Vaccines
RNAimmune, Inc., a biopharmaceutical company specializing in discovery and development of mRNA-based therapeutics and vaccines
Posted on 8/24/20
Forget Moderna: Novavax Is the Coronavirus Vaccine Stock You'll Really Want to Watch
Moderna (NASDAQ:MRNA) ranks as one of the most talked-about biotechs around. Its rapid progress in developing a coronavirus vaccine candidate catapulted the company into the national . . .
Posted on 8/24/20
Can Novavax's Coronavirus Vaccine Be Valued?
It doesn't surprise me that a small-cap biotech company like Novavax (NASDAQ:NVAX) skyrocketed when the COVID-19 pandemic began. Millions of people will need to be vaccinated . . .
Washington DC
